#AstraZeneca for the first time admits its Covishield vaccine may lead to rare side effect
22445 Tuesday, 30 April, 2024, 23:24 AstraZeneca has admitted for the first time in court documents that its Covid-19 vaccine, sold globally under the brand names Covishield and Vaxzevria among others, may lead to a rare side-effect. Covishield can cause, in rare cases, a condition that leads to blood clots and low platelet count, the vaccine-maker has said in court documents. This condition is known as Thrombosis with Thrombocytopenia Syndrome (TTS). Covishield was produced by the Serum Institute of India and widely administered in the country. AstraZeneca is facing a class action lawsuit in the UK over claims that its vaccine caused deaths and severe injuries in several cases. |
"Don't lose hope if you struggle with acne," advises Dr. Maria Novosartyan (photo)
81409.01.2025, 22:06U.S. records its first human bird flu death
283907.01.2025, 10:31China says it has shared the most COVID-19 data among countries
257501.01.2025, 06:06US engages Pentagon contractors who worked in Armenia in Senegal — top brass
583424.12.2024, 18:25Doctors remove live cockroach from intestine after Delhi man complains of stomach ache (photo)
1164920.10.2024, 18:54The horrifying details of the “newborn gang” scandal in Türkiye have rocked the nation
1135719.10.2024, 01:06'Out of darkness, can come light': Kate's message in full (video)
1236909.09.2024, 22:12Over 70 factories in Ashulia shut down amid workers’ protests
1271704.09.2024, 20:24